Skip to main content
Sanjivani Paranteral Ltd. logo

Sanjivani Paranteral Ltd. — Investor Relations & Filings

Ticker · 531569 ISIN · INE860D01013 LEI · 894500D9X5K9PU8CXI51 BSE.NS Manufacturing
Open in API
Filings indexed 10 across all filing types
Latest filing 2026-05-21 Share Issue/Capital Cha…
Country IN India
Listing BSE.NS 531569

About Sanjivani Paranteral Ltd.

https://www.sanjivani.co.in/

Sanjivani Paranteral Ltd. specializes in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations. The company focuses on high-quality parenteral products, including small volume parenterals and large volume parenterals, alongside oral solids such as tablets and capsules. Its product portfolio spans multiple therapeutic categories, including anti-infectives, analgesics, cardiovascular agents, and gastrointestinal treatments. Operating with WHO-GMP certified facilities, the company provides contract manufacturing services and exports its products to various international markets. Sanjivani Paranteral Ltd. emphasizes research and development to enhance its formulation capabilities and maintain compliance with global regulatory standards.

Recent filings

Filing Released Lang Actions
Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), ....
Share Issue/Capital Change Classification · 85% confidence The document is a Board meeting outcome announcement under SEBI Listing Regulations informing of the Board’s approval to appoint a valuer for pricing a proposed preferential issue of warrants (a capital raising via share issuance). It is not a management change or full report, but specifically details a planned share issuance. According to the definitions, this falls under Share Issue/Capital Change (SHA).
2026-05-21 English
Earnings call Transcript as on dated 15th May, 2026
Call Transcript Classification · 95% confidence The document is a transcript of the company’s Q4 FY 2026 earnings conference call, including the opening remarks, management presentations, and Q&A session with analysts. This matches the definition of a Call Transcript (CT).
2026-05-20 English
As per Attached Document.
Report Publication Announcement Classification · 82% confidence The document is a formal notice to the stock exchange under SEBI Listing Regulations, stating that the Board has approved the audited financial results for the quarter and year ended 31 March 2026 and that an advertisement of those results has been published in newspapers. It does not contain the full financial statements or detailed results itself, but merely announces the publication of the audited results in the press. This fits the definition of a “Report Publication Announcement” (RPA).
2026-05-16 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the earnings call with analysts and investors held on 15th ....
Report Publication Announcement Classification · 85% confidence The document is a short notice under SEBI LODR Regulation 30 informing the exchange that the audio recording of the Q4 and full-year earnings call (March 31, 2026) has been made available on the company website. It does not contain actual financial data or the transcript itself, but simply announces the publication of the recording. This aligns with a Report Publication Announcement (RPA).
2026-05-16 English
As per attached Document
Earnings Release Classification · 88% confidence The document is a press release under SEBI LODR Regulation 30 announcing the company’s audited financial results for Q4 and FY26, including key consolidated financial highlights (total income, EBITDA, PAT, margins, EPS) and management commentary. It is not the full annual report or audit opinion but an earnings announcement with summary financial metrics. This aligns with an Earnings Release (ER). FY 2026
2026-05-15 English
Sanjivani Paranteral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve the proposal for raising ....
Regulatory Filings Classification · 80% confidence The document is a formal notice to the exchange under SEBI LODR, informing of a Board meeting date and agenda (including consideration of a capital raise). It does not itself present financial statements or a report, nor announce a dividend, share issue consummation, or management change. It is a generic regulatory/compliance announcement. This fits the fallback category Regulatory Filings (RNS).
2026-05-15 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.